Drug intelligence / Profile preview

FemBalance

Development stage: Unknown
Lead developer: Kizer Wellness
Administration: Oral

Overview

FemBalance is an oral nutraceutical supplement developed by IGP Mediventures Pvt. Ltd. designed to support women's reproductive health and hormonal balance. The formulation is based on Ayurvedic principles and contains a blend of traditional herbal extracts, including Ashok Chal (Saraca asoca), Lodhra (Symplocos racemosa), Shatavari (Asparagus racemosus), and Manjistha (Rubia cordifolia). These ingredients are traditionally utilized in Indian medicine to regulate menstrual cycles, support uterine health, and maintain overall hormonal equilibrium. As a dietary supplement, it is marketed for general wellness and supportive care rather than as a pharmaceutical drug with a defined molecular mechanism of action.

Brand names: FemBalanceIGP'S FEMBALANCE CAPSULES

Beyond the preview

Go deeper on FemBalance.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

Trial phase
Status
Readouts

Indications & development

Explore development by indication, patient population, and geography.

Indications
Development status
Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

Partners
Deal terms
Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

Patents
Expiration dates
Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

Competing assets
Targets
Development stage

Research & analysis

Connect source evidence and development news to your research questions.

Publications
News
Analysis

Bring the full picture into focus.

See how Gosset can support your research on FemBalance.

Explore the full profile